According to a recent LinkedIn post from Synapticure, the company’s Movement Disorders Director, Dr. Elizabeth Ferluga, is scheduled to speak at an APDA Georgia Chapter educational workshop on March 13 in Sandy Springs, Ga. The session, joined by Emory School of Medicine’s Dr. Cristina Pritchett, is described as focusing on how telehealth can expand access to neurological care, mental health support, and wellness resources for people living with Parkinson’s disease.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Synapticure is positioning its clinical leadership within the Parkinson’s community and aligning its brand with telehealth-enabled, multidisciplinary care. For investors, this type of thought-leadership visibility may support long-term demand generation, particularly if Synapticure’s virtual care model can capture patients seeking between-visit support and remote access to specialists.
The emphasis on emotional well-being, confidence, and continuous access to care highlights a broader care model that could translate into higher patient engagement and retention. If Synapticure can convert educational outreach and advocacy collaborations into structured referral channels or partnerships, it may enhance its competitive stance in the neurology-focused telehealth and digital health markets.
Participation in a program hosted by the APDA Georgia Chapter and a Center for Movement Challenges also indicates ongoing relationship-building with nonprofit and academic stakeholders. Such collaborations could strengthen clinical credibility, support data generation for outcomes-based storytelling, and potentially underpin future reimbursement discussions around remote Parkinson’s care and mental health services.